Bayer Says Failed NAVIGATE Trial Won’t Affect Xarelto Sales Projections
Filed in: Xarelto
References
https://www.jnj.com/media-center/press-releases/navigate-esus-study-stopped-early-due-to-comparable-efficacy-in-treatment-arms https://pharmaphorum.com/news/bayer-bms-xarelto-failure/#
http://www.fiercepharma.com/financials/big-trial-failure-for-xarelto-clot-prevention-won-t-affect-sales-bayer-vows https://www.biopharmadive.com/news/portola-andexxa-bla-approval-review/449368/